跨国药企业绩大爆发,集体加仓中国

21世纪经济报道
May 07

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!   记者丨季媛媛   编辑丨张伟贤   2026年第一季度,全球制药巨头的业绩版图再度刷新。   一边,礼来凭借替尔泊肽的强势爆发点燃增长引擎,诺和诺德用司美格鲁肽四条管线合计突破528亿丹麦克朗全线扩张;另一边,默沙东在K药顶住专利竞争压力的同时开始培育新一代增长点,赛诺菲以Dupixent续写自免领域的统治传奇。   在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10